Chronic hepatitis B virus infection in children and adolescents in Japan

Journal of Pediatric Gastroenterology and Nutrition

Volumn 60, Issue 1, 2015, Pages 99-104

  Komatsu, Haruki ^a   Inui, Ayano ^b   Sogo, Tsuyoshi ^b   Tsunoda, Tomoyuki ^b   Fujisawa, Tomoo ^b  

^a TOHO UNIVERSITY   (Japan)

^b Eastern Yokohama Hospital   (Japan)

Author keywords

alanine aminotransferase; genotype; hepatitis B e antigen; interferon; perinatal transmission; seroconversion

Indexed keywords

ALANINE AMINOTRANSFERASE; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE; PEGINTERFERON; PREDNISOLONE; HEPATITIS B ANTIBODIES;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; INFANT; JAPAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROCONVERSION; VIRUS TRANSMISSION; CHILD, PRESCHOOL; COHORT STUDIES; FOLLOW-UP STUDIES; GROWTH AND DEVELOPMENT; HEPATITIS B, CHRONIC; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGY; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; ISOLATION AND PURIFICATION; KAPLAN-MEIER ESTIMATE; LIVER; PHYSIOPATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDIES; TRANSMISSION; VIRAL LOAD; VIROLOGY; YOUNG ADULT;

HEPATITIS B VIRUS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNE TOLERANCE; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; JAPAN; KAPLAN-MEIER ESTIMATE; LIVER; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; VIRAL LOAD; YOUNG ADULT;

EID: 84920771685     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000567     Document Type: Article

References (33)

1. World Health Organaization. Global Alert and Response (GAR). Hepatitis B http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/ en/index1.html.
2. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008;48:335-52.
3. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009;373:582-92.
4. Yapali S, Talaat N, Lok AS. Management of hepatitis B: our practice and how it relates to the guidelines. Clin Gastroenterol Hepatol 2014;12:16-26.
5. Hsu YS, Chien RN, Yeh CT, et al. Long-Term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002;35:1522-7.
6. Fattovich G, Olivari N, Pasino M, et al. Long-Term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years. Gut 2008; 57:84-90.
7. Bortolotti F, Guido M, Bartolacci S, et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology 2006;43:556-62.
8. Paganelli M, Stephenne X, Sokal EM. Chronic hepatitis B in children and adolescents. J Hepatol 2012;57:885-96.
9. Sokal EM, Paganelli M,Wirth S, et al. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Hepatol 2013;59:814-29.
10. Di Bisceglie AM. Hepatitis B and hepatocellular carcinoma. Hepatology 2009;49(5 Suppl):S56-60.
11. Lim SG, Mohammed R, Yuen MF, et al. Prevention of hepatocellular carcinoma in hepatitis B virus infection. J Gastroenterol Hepatol 2009;24:1352-7.
12. Hsu HY, Tsai HY, Wu TC, et al. Interferon-Alpha treatment in children and young adults with chronic hepatitis B: a long-Term follow-up study in Taiwan. Liver Int 2008;28:1288-97.
13. Ni YH, Chang MH, Chen PJ, et al. Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion. Gastroenterology 2007;132:2340-5.
14. Lok AS, Lai CL. A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive Chinese children. Hepatology 1988;8:1130-3.
15. Fujisawa T, Komatsu H, Inui A, et al. Long-Term outcome of chronic hepatitis B in adolescents or young adults in follow-up from childhood. J Pediatr Gastroenterol Nutr 2000;30:201-6.
16. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012;57:167-85.
17. Moriya T, Kuramoto IK, Yoshizawa H, et al. Distribution of hepatitis B virus genotypes among American blood donors determined with a PreS2 epitope enzyme-linked immunosorbent assay kit. J Clin Microbiol 2002;40:877-80.
18. Tadokoro K, Kobayashi M, Yamaguchi T, et al. Classification of hepatitis B virus genotypes by the PCR-Invader method with genotype-specific probes. J Virol Methods 2006;138:30-9.
19. Chu CM, Liaw YF. Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion. J Viral Hepat 2007;14:147-52.
20. Liaw YF, Lau GK, Kao JH, et al. Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection. Dig Dis Sci 2010;55:2727-34.
21. Yeung LT, Roberts EA. Current issues in the management of paediatric viral hepatitis. Liver Int 2010;30:5-18.
22. Jonas MM, Block JM, Haber BA, et al. Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hepatology 2010;52:2192-205.
23. Choe HJ, Choe BH. What physicians should know about the management of chronic hepatitis B in children: east side story. World J Gastroenterol 2014;20:3582-9.
24. Marx G, Martin SR, Chicoine JF, et al. Long-Term follow-up of chronic hepatitis B virus infection in children of different ethnic origins. J Infect Dis 2002;186:295-301.
25. Vo Thi Diem H, Bourgois A, Bontems P, et al. Chronic hepatitis B infection: long term comparison of children receiving interferon alpha and untreated controls. J Pediatr Gastroenterol Nutr 2005;40:141-5.
26. Boxall EH, Sira J, Ballard AL, et al. Long-Term follow-up of hepatitis B carrier children treated with interferon and prednisolone. J Med Virol 2006;78:888-95.
27. Popalis C, Yeung LT, Ling SC, et al. Chronic hepatitis B virus (HBV) infection in children: 25 years' experience. J Viral Hepat 2013;20:e20-6.
28. Zacharakis G, Koskinas J, Kotsiou S, et al. Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years' follow-up in northern Greece. J Pediatr Gastroenterol Nutr 2007;44:84-91.
29. Bortolotti F, Jara P, Barbera C, et al. Long term effect of alpha interferon in children with chronic hepatitis B. Gut 2000;46:715-8.
30. Mohan N, Gonzalez-Peralta RP, Fujisawa T, et al. Chronic hepatitis C virus infection in children. J Pediatr Gastroenterol Nutr 2010;50:123-31.
31. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002;2:395-403.
32. Panessa C, Hill WD, Giles E, et al. Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia. J Viral Hepat 2009;16:64-73.
33. Jonas MM, Mizerski J, Badia IB, et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 2002;346:1706-13.